Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Ранг среди акций #18091
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Цена акции
$4.47
Последняя синхронизация: 2025-08-20
Рыночная капитализация
$213.06M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля CARGO Therapeutics, Inc. Common Stock (CRGX)

Категория

Коэффициент P/B для CARGO Therapeutics, Inc. Common Stock (CRGX)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций CARGO Therapeutics, Inc. Common Stock, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для CARGO Therapeutics, Inc. Common Stock с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH